STOCK TITAN

[Form 4] USANA HEALTH SCIENCES INC Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

USANA Health Sciences (USNA) reported a director’s acquisition of 1,057 shares of common stock on 10/23/2025, coded “M” for settlement of restricted stock units.

After the transaction, the reporting person beneficially owns 1,057 shares directly and 2,115 restricted stock units. The RSUs vest 25% on July 24, 2025, October 23, 2025, January 22, 2026, and April 23, 2026.

USANA Health Sciences (USNA) ha riferito l'acquisizione da parte di un amministratore di 1.057 azioni ordinarie in data 23 ottobre 2025, codificata come “M” per la regolamentazione delle unità azionarie vincolate.

Dopo la transazione, la persona che riferisce possiede direttamente 1.057 azioni e 2.115 unità azionarie vincolate. Le RSU maturano al 25% il 24 luglio 2025, 23 ottobre 2025, 22 gennaio 2026 e 23 aprile 2026.

USANA Health Sciences (USNA) informó la adquisición por parte de un director de 1,057 acciones comunes el 23/10/2025, codificada como “M” para el asentamiento de unidades de acciones restringidas.

Después de la transacción, la persona que reporta posee de forma beneficiosa 1,057 acciones directamente y 2,115 unidades de acciones restringidas. Las RSU vencen en un 25% el 24 de julio de 2025, 23 de octubre de 2025, 22 de enero de 2026 y 23 de abril de 2026.

USANA Health Sciences (USNA) 이사는 2025년 10월 23일에 1,057주의 보통주를 취득했다고 보고했습니다. 이는 제한 주식 단위의 결제를 위한 “M”로 표시되었습니다.

거래 후 보고자는 직접 1,057주2,115개의 제한 주식 단위를 유익하게 소유합니다. RSU는 25%가 2025년 7월 24일, 2025년 10월 23일, 2026년 1월 22일, 2026년 4월 23일에 취득됩니다.

USANA Health Sciences (USNA) a annoncé l'acquisition par un administrateur de 1 057 actions ordinaires le 23 octobre 2025, codée “M” pour le règlement des unités d'actions restreintes.

Après la transaction, la personne déclarante détient directement 1 057 actions et 2 115 unités d'actions restreintes. Les RSU se libèrent à hauteur de 25 % le 24 juillet 2025, le 23 octobre 2025, le 22 janvier 2026 et le 23 avril 2026.

USANA Health Sciences (USNA) meldete den Erwerb von 1.057 Stammaktien durch einen Direktor am 23.10.2025, kodiert mit „M“ zur Abrechnung von Restricted Stock Units.

Nach der Transaktion besitzt die meldepflichtige Person direkt 1.057 Aktien und 2.115 RSUs. Die RSUs vesten zu 25% am 24. Juli 2025, am 23. Oktober 2025, am 22. Januar 2026 und am 23. April 2026.

USANA Health Sciences (USNA) أبلَغت عن استحواذ من قبل مدير على 1,057 سهمًا عاديًا في تاريخ 23/10/2025، وموشَّح برمز “M” لتسوية وحدات الأسهم المقيدة.

بعد الصفقة، يمتلك الشخص المبلِّغ عنه بشكل مفيد 1,057 سهمًا مباشرة و2,115 وحدة أسهم مقيدة. وتتحقق vesting RSU بنسبة 25% في 24 يوليو 2025 و23 أكتوبر 2025 و22 يناير 2026 و23 أبريل 2026.

Positive
  • None.
Negative
  • None.

USANA Health Sciences (USNA) ha riferito l'acquisizione da parte di un amministratore di 1.057 azioni ordinarie in data 23 ottobre 2025, codificata come “M” per la regolamentazione delle unità azionarie vincolate.

Dopo la transazione, la persona che riferisce possiede direttamente 1.057 azioni e 2.115 unità azionarie vincolate. Le RSU maturano al 25% il 24 luglio 2025, 23 ottobre 2025, 22 gennaio 2026 e 23 aprile 2026.

USANA Health Sciences (USNA) informó la adquisición por parte de un director de 1,057 acciones comunes el 23/10/2025, codificada como “M” para el asentamiento de unidades de acciones restringidas.

Después de la transacción, la persona que reporta posee de forma beneficiosa 1,057 acciones directamente y 2,115 unidades de acciones restringidas. Las RSU vencen en un 25% el 24 de julio de 2025, 23 de octubre de 2025, 22 de enero de 2026 y 23 de abril de 2026.

USANA Health Sciences (USNA) 이사는 2025년 10월 23일에 1,057주의 보통주를 취득했다고 보고했습니다. 이는 제한 주식 단위의 결제를 위한 “M”로 표시되었습니다.

거래 후 보고자는 직접 1,057주2,115개의 제한 주식 단위를 유익하게 소유합니다. RSU는 25%가 2025년 7월 24일, 2025년 10월 23일, 2026년 1월 22일, 2026년 4월 23일에 취득됩니다.

USANA Health Sciences (USNA) a annoncé l'acquisition par un administrateur de 1 057 actions ordinaires le 23 octobre 2025, codée “M” pour le règlement des unités d'actions restreintes.

Après la transaction, la personne déclarante détient directement 1 057 actions et 2 115 unités d'actions restreintes. Les RSU se libèrent à hauteur de 25 % le 24 juillet 2025, le 23 octobre 2025, le 22 janvier 2026 et le 23 avril 2026.

USANA Health Sciences (USNA) meldete den Erwerb von 1.057 Stammaktien durch einen Direktor am 23.10.2025, kodiert mit „M“ zur Abrechnung von Restricted Stock Units.

Nach der Transaktion besitzt die meldepflichtige Person direkt 1.057 Aktien und 2.115 RSUs. Die RSUs vesten zu 25% am 24. Juli 2025, am 23. Oktober 2025, am 22. Januar 2026 und am 23. April 2026.

USANA Health Sciences (USNA) أبلَغت عن استحواذ من قبل مدير على 1,057 سهمًا عاديًا في تاريخ 23/10/2025، وموشَّح برمز “M” لتسوية وحدات الأسهم المقيدة.

بعد الصفقة، يمتلك الشخص المبلِّغ عنه بشكل مفيد 1,057 سهمًا مباشرة و2,115 وحدة أسهم مقيدة. وتتحقق vesting RSU بنسبة 25% في 24 يوليو 2025 و23 أكتوبر 2025 و22 يناير 2026 و23 أبريل 2026.

USANA Health Sciences (USNA) 报告称,一名董事于 2025年10月23日 收购了 1,057 股普通股,交易代码为“M”用于结算受限股票单位。

交易后,申报人直接持有 1,057 股,并持有 2,115 单位受限股票。RSU 将在 2025年7月24日2025年10月23日2026年1月22日2026年4月23日 分别归属 25%。

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
FULLER GILBERT A

(Last) (First) (Middle)
3838 WEST PARKWAY BLVD

(Street)
SALT LAKE CITY UT 84120

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
USANA HEALTH SCIENCES INC [ USNA ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
10/23/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 10/23/2025 M 1,057 A (1) 1,057 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Units (1) 10/23/2025 M 1,057 (2) (2) Common Stock 1,057 $0 2,115 D
Explanation of Responses:
1. Each restricted stock unit represents a contingent right to receive one share of USNA common stock.
2. Restricted Stock Units vest 25% on July 24, 2025, October 23, 2025, January 22, 2026, and April 23, 2026.
Remarks:
/s/ Joshua Foukas, Attorney-in-Fact 10/27/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did USNA (USNA) disclose in this Form 4?

A director acquired 1,057 shares of common stock on 10/23/2025 under transaction code M, reflecting settlement of restricted stock units.

How many USANA shares does the reporting person own directly after the transaction?

The reporting person beneficially owns 1,057 shares directly following the transaction.

How many restricted stock units (RSUs) remain after this transaction for USNA?

The reporting person holds 2,115 restricted stock units after the reported transaction.

What is the vesting schedule for the USNA restricted stock units?

The RSUs vest 25% on July 24, 2025, October 23, 2025, January 22, 2026, and April 23, 2026.

What does transaction code M indicate in this USNA Form 4?

Code M indicates the settlement of a derivative security; here, 1,057 RSUs converted into 1,057 shares of common stock at $0 for the derivative security.
Usana Health Sciences Inc

NYSE:USNA

USNA Rankings

USNA Latest News

USNA Latest SEC Filings

USNA Stock Data

358.31M
10.40M
42.93%
61.22%
3.86%
Packaged Foods
Medicinal Chemicals & Botanical Products
Link
United States
SALT LAKE CITY